Trade DXCM anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
DexCom, Inc. (DXCM) is trading at US$90.67, up 1.54% today as of Aug 28, 11:37 EDT. The company has a market capitalisation of US$34.85B. Over the past 52 weeks, DXCM has traded between US$54.11 and US$92.59. On Syfe you can trade DXCM with $0 commission and add it to your watchlist.
| Previous close | US$89.29 |
|---|---|
| Market cap | US$34.85B |
| P/E ratio | 30.31 |
| 52-week range | US$54.11 – US$92.59 |
| Volume | 3.01M |
| Exchange | US |
Add to Watchlist
Set Price Alert
DexCom, Inc.
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Year: 2005
DexCom, Inc. (DXCM) stock is trading at US$90.67, +1.54% from the previous close of US$89.29.
The market cap for DexCom, Inc. (DXCM) stock is approximately US$34.85B.
The price-to-earnings ratio for DexCom, Inc. (DXCM) is 30.31, based on the latest reported earnings.
The 52-week high for DexCom, Inc. (DXCM) stock is US$92.59.
The 52-week low for DexCom, Inc. (DXCM) stock is US$54.11.
DexCom, Inc. (DXCM) does not currently pay a dividend.
Stay on top of DXCM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
